1
This exploratory study assessed whether emricasan lowers PH in patients with compensated cirrhosis.
2
The results did not reveal systematic neurophysiologic disturbances in persons with well compensated cirrhosis.
3
Various critical events, liver related or not, occur in patients with compensated cirrhosis, but their respective burden remains to be prospectively assessed.
4
Participation was higher among patients with compensated cirrhosis or hepatitis C infections; it was lower among those with alcohol-related liver disease or decompensated liver disease.
5
Results: At first visit, all subjects were confirmed as patients with compensated cirrhosis, 39 by liver biopsy and 68 by standard laboratory and radiological criteria.